Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study

Monday, August 19, 2024 1 min read

Key Takeaway: Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study

Full Press Release Details

Monte Rosa Therapeutics Announces First Participants Dosed in MRT-6160 Phase 1 Study.